Hemostatic defects in end stage liver disease

Critical Care Clinics

Volumn 21, Issue 3 SPEC. ISS., 2005, Pages 563-587

  Kujovich, Jody L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; CORTICOSTEROID; IMMUNOGLOBULIN G; RECOMBINANT BLOOD CLOTTING FACTOR 7A; VITAMIN K GROUP;

BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG SAFETY; FIBRINOLYSIS; HEMOSTASIS; HUMAN; INTRACRANIAL PRESSURE; LABORATORY DIAGNOSIS; LIVER BIOPSY; LIVER DISEASE; PARACENTESIS; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCLEROTHERAPY; SUBSTITUTION THERAPY; SURVIVAL; THORACOCENTESIS; THROMBOCYTE COUNT; THROMBOCYTE DISORDER; THROMBOCYTE DYSFUNCTION; THROMBOCYTOPENIA; THROMBOSIS; VITAMIN K DEFICIENCY;

EID: 21244494426     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2005.03.002     Document Type: Review

References (179)

1. R.N. Pugh, I.M. Murray-Lyon, and J.L. Dawson Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 1973 646 649
2. E. Rodriguez-Inigo, J. Bartolome, and J.A. Quiroga Expression of factor VII in the liver of patients with liver disease: correlations with the disease severity and impairment in the hemostasis Blood Coagul Fibrinolysis 12 2001 193 199
3. M.J. Hollestelle, H.G. Geertzen, and I.H. Straatsburg Factor VIII expression in liver disease Thromb Haemost 91 2004 267 275
4. G. Green, L. Poller, and J.M. Thomson Factor VII as a marker of hepatocellular synthetic function in liver disease J Clin Pathol 29 1976 971 975
5. S.R. Deitcher Interpretation of the international normalised ratio in patients with liver disease Lancet 359 2002 47 48
6. A. Hallen, and I.M. Nilsson Coagulation studies in liver disease Thromb Diath Haemorrh 11 1964 51 63
7. H.G. Kupfer, W. Gee, and A.T. Ewald Statistical correlation of liver function tests with coagulation factor deficiencies in Laennec's cirrhosis Thromb Diath Haemorrh 10 1964 317 331
8. R. Kerr New insights into haemostasis in liver failure Blood Coagul Fibrinolysis 14 Suppl 1 2003 S43 S45
9. M.J. Kovacs, A. Wong, and K. MacKinnon Assessment of the validity of the INR system for patients with liver impairment Thromb Haemost 71 1994 727 730
10. L. Biland, F. Duckert, and S. Prisender Quantitative estimation of coagulation factors in liver disease. The diagnostic and prognostic value of factor XIII, factor V and plasminogen Thromb Haemost 39 1978 646 656
11. D.E. Bernstein, L. Jeffers, and E. Erhardtsen Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study Gastroenterology 113 1997 1930 1937
12. G. Green, J.M. Thomson, and I.W. Dymock Abnormal fibrin polymerization in liver disease Br J Haematol 34 1976 427 439
13. D.A. Kelly, and E.G. Tuddenham Haemostatic problems in liver disease Gut 27 1986 339 349
14. J.L. Francis, and D.J. Armstrong Acquired dysfibrinogenaemia in liver disease J Clin Pathol 35 1982 667 672
15. H.R. Roberts, T.E. Stinchcombe, and D.A. Gabriel The dysfibrinogenaemias Br J Haematol 114 2001 249 257
16. R.A. Blanchard, B.C. Furie, and M. Jorgensen Acquired vitamin K-dependent carboxylation deficiency in liver disease N Engl J Med 305 1981 242 248
17. B.G. Gazzard, J.M. Henderson, and R. Williams Factor VII levels as a guide to prognosis in fulminant hepatic failure Gut 17 1976 489 491
18. A.L. Boks, E.J. Brommer, and S.W. Schalm Hemostasis and fibrinolysis in severe liver failure and their relation to hemorrhage Hepatology 6 1986 79 86
19. K.Q. Hu, A.S. Yu, and L. Tiyyagura Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit Am J Gastroenterol 96 2001 1581 1586
20. F. Violi, D. Ferro, and S. Basili Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with advanced cirrhosis Hepatology 15 1992 672 676
21. F. Violi, D. Ferro, and S. Basili Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis Hepatology 17 1993 78 83
22. F.W. Leebeek, C. Kluft, and E.A. Knot A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis Gastroenterology 101 1991 1382 1390
23. F. Violi, S. Basili, and D. Ferro Association between high values of D-dimer and tissue-plasminogen activator activity and first gastrointestinal bleeding in cirrhotic patients Thromb Haemost 76 1996 177 183
24. A.P. Fletcher, O. Biederman, and D. Moore Abnormal plasminogen-plasmin system activity (fibrinolysis) in patients with hepatic cirrhosis: its cause and consequences J Clin Invest 43 1964 681 695
25. T. Lisman, F.W. Leebeek, and L.O. Mosnier Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis Gastroenterology 121 2001 131 139
26. M. Colucci, B.M. Binetti, and M.G. Branca Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis Hepatology 38 2003 230 237
27. D.H. Van Thiel, M. George, and J. Fareed Low levels of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with chronic liver disease Thromb Haemost 85 2001 667 670
28. S. Agarwal, K.A. Joyner Jr, and M.W. Swaim Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease Am J Gastroenterol 95 2000 3218 3224
29. R.J. Porte, F.A. Bontempo, and E.A. Knot Tissue-type-plasminogen- activator-associated fibrinolysis in orthotopic liver transplantation Transplant Proc 21 1989 3542
30. P.L. Harper, R.J. Luddington, and I. Jennings Coagulation changes following hepatic revascularization during liver transplantation Transplantation 48 1989 603 607
31. J.H. Lewis, F.A. Bontempo, and S.A. Awad Liver transplantation: intraoperative changes in coagulation factors in 100 first transplants Hepatology 9 1989 710 714
32. A. Steib, N. Gengenwin, and G. Freys Predictive factors of hyperfibrinolytic activity during liver transplantation in cirrhotic patients Br J Anaesth 73 1994 645 648
33. A. Gutierrez, J. Sanchez-Paya, and P. Marco Prognostic value of fibrinolytic tests for hospital outcome in patients with acute upper gastrointestinal hemorrhage J Clin Gastroenterol 32 2001 315 318
34. R.B. Francis Jr, and D.I. Feinstein Clinical significance of accelerated fibrinolysis in liver disease Haemostasis 14 1984 460 465
35. B.S. Kahl, B.S. Schwartz, and D.F. Mosher Profound imbalance of pro-fibrinolytic and anti-fibrinolytic factors (tissue plasminogen activator and plasminogen activator inhibitor type 1) and severe bleeding diathesis in a patient with cirrhosis: correction by liver transplantation Blood Coagul Fibrinolysis 14 2003 741 744
36. F.N. Bashour, J.C. Teran, and K.D. Mullen Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease Am J Gastroenterol 95 2000 2936 2939
37. N. Jabbour, A. Zajko, and P. Orons Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis? Dig Dis Sci 43 1998 2459 2462
38. R.H. Aster Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia J Clin Invest 45 1966 645 657
39. L.A. Harker, and C.A. Finch Thrombokinetics in man J Clin Invest 48 1969 963 974
40. S.F. Stein, and L.A. Harker Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis J Lab Clin Med 99 1982 217 230
41. E. Giannini, F. Botta, and P. Borro Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection Am J Gastroenterol 98 2003 2516 2520
42. L.E. Adinolfi, M.G. Giordano, and A. Andreana Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis Br J Haematol 113 2001 590 595
43. T. Kawasaki, A. Takeshita, and K. Souda Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis Am J Gastroenterol 94 1999 1918 1922
44. A. Sanjo, J. Satoi, and A. Ohnishi Role of elevated platelet-associated immunoglobulin G and hypersplenism in thrombocytopenia of chronic liver diseases J Gastroenterol Hepatol 18 2003 638 644
45. P.J. Toghill, S. Green, and F. Ferguson Platelet dynamics in chronic liver disease with special reference to the role of the spleen J Clin Pathol 30 1977 367 371
46. P.J. Toghill, and S. Green Platelet dynamics in chronic liver disease using the 111Indium oxine label Gut 24 1983 49 52
47. J. Goulis, T.N. Chau, and S. Jordan Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation Gut 44 1999 754 758
48. E. Giannini, P. Borro, and F. Botta Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis J Hepatol 37 2002 572 577
49. W. Yongxiang, L. Zongfang, and L. Guowei Effects of splenomegaly and splenic macrophage activity in hypersplenism due to cirrhosis Am J Med 113 2002 428 431
50. A.J. Sanyal, A.M. Freedman, and P.P. Purdum The hematologic consequences of transjugular intrahepatic portosystemic shunts Hepatology 23 1996 32 39
51. Z. Karasu, A. Gurakar, and B. Kerwin Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis Dig Dis Sci 45 2000 1971 1976
52. M.G. Mutchnick, E. Lerner, and H.O. Conn Effect of portacaval anastomosis on hypersplenism Dig Dis Sci 25 1980 929 938
53. B.H. Sullivan Jr, and H.J. Tumen The effect of portacaval shunt on thrombocytopenia associated with portal hypertension Ann Intern Med 55 1961 598 603
54. W.R. Felix Jr, R.M. Myerson, and B. Sigel The effect of portacaval shunt on hypersplenism Surg Gynecol Obstet 139 1974 899 904
55. I. Kamisasa, K. Hidai, and M. Sugiura Effects of splenectomy on blood coagulation and fibrinolysis in patients with liver cirrhosis: possible role of the spleen in haemostasis. Thrombos Haemostas 42 1979 1529 1535
56. S. Liangpunsakul, B.J. Ulmer, and N. Chalasani Predictors and implications of severe hypersplenism in patients with cirrhosis Am J Med Sci 326 2003 111 116
57. Y. Koike, A. Yoneyama, and J. Shirai Evaluation of thrombopoiesis in thrombocytopenic disorders by simultaneous measurement of reticulated platelets of whole blood and serum thrombopoietin concentrations Thromb Haemost 79 1998 1106 1110
58. A. Panasiuk, D. Prokopowicz, and J. Zak Reticulated platelets as a marker of megakaryopoiesis in liver cirrhosis; relation to thrombopoietin and hepatocyte growth factor serum concentration Hepatogastroenterology 51 2004 1124 1128
59. D.J. Kuter, and C.G. Begley Recombinant human thrombopoietin: basic biology and evaluation of clinical studies Blood 100 2002 3457 3469
60. T.G. Martin III, K.A. Somberg, and Y.G. Meng Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation Ann Intern Med 127 1997 285 288
61. T. Ishikawa, T. Ichida, and Y. Matsuda Reduced expression of thrombopoietin is involved in thrombocytopenia in human and rat liver cirrhosis J Gastroenterol Hepatol 13 1998 907 913
62. M. Peck-Radosavljevic, M. Wichlas, and J. Zacherl Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production Blood 95 2000 795 801
63. M. Peck-Radosavljevic, J. Zacherl, and Y.G. Meng Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver? J Hepatol 27 1997 127 131
64. K. Yanaga, A.G. Tzakis, and M. Shimada Reversal of hypersplenism following orthotopic liver transplantation Ann Surg 210 1989 180 183
65. M. Peck-Radosavljevic Thrombocytopenia in liver disease Can J Gastroenterol 14 Suppl D 2000 60D 66D
66. J. Pereira, L. Accatino, and J. Alfaro Platelet autoantibodies in patients with chronic liver disease Am J Hematol 50 1995 173 178
67. H. Samuel, M. Nardi, and M. Karpatkin Differentiation of autoimmune thrombocytopenia from thrombocytopenia associated with immune complex disease: systemic lupus erythematosus, hepatitis-cirrhosis, and HIV-1 infection by platelet and serum immunological measurements Br J Haematol 105 1999 1086 1091
68. T. Nagamine, T. Ohtuka, and K. Takehara Thrombocytopenia associated with hepatitis C viral infection J Hepatol 24 1996 135 140
69. D. Graber, D. Giuliani, and C.M. Leevy Platelet-associated IgG in hepatitis and cirrhosis J Clin Immunol 4 1984 108 111
70. R. de Noronha, B.A. Taylor, and G. Wild Inter-relationships between platelet count, platelet IgG, serum IgG, immune complexes and severity of liver disease Clin Lab Haematol 13 1991 127 135
71. M. Kajihara, S. Kato, and Y. Okazaki A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis Hepatology 37 2003 1267 1276
72. P.J. Pockros, A. Duchini, and R. McMillan Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection Am J Gastroenterol 97 2002 2040 2045
73. F. Bauduer, F. Marty, and M. Larrouy Immunologic thrombocytopenic purpura as presenting symptom of hepatitis C infection Am J Hematol 57 1998 338 340
74. M. Ramos-Casals, M. Garcia-Carrasco, and F. Lopez-Medrano Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases Medicine (Baltimore) 82 2003 87 96
75. F. Hernandez, A. Blanquer, and M. Linares Autoimmune thrombocytopenia associated with hepatitis C virus infection Acta Haematol 99 1998 217 220
76. J.C. Blake, D. Sprengers, and P. Grech Bleeding time in patients with hepatic cirrhosis BMJ 301 1990 12 15
77. F. Violi, R. Leo, and E. Vezza Bleeding time in patients with cirrhosis: relation with degree of liver failure and clotting abnormalities J Hepatol 20 1994 531 536
78. W.C. Hsu, F.Y. Lee, and S.D. Lee Prolonged bleeding time in cirrhotic patients: relationship to peripheral vasodilation and severity of cirrhosis J Gastroenterol Hepatol 9 1994 437 441
79. S. Basili, D. Ferro, and R. Leo Bleeding time does not predict gastrointestinal bleeding in patients with cirrhosis J Hepatol 24 1996 574 580
80. G. Escolar, A. Cases, and M. Vinas Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100): influence of hematocrit elevation Haematologica 84 1999 614 619
81. H.S. Ballard, and A.J. Marcus Platelet aggregation in portal cirrhosis Arch Intern Med 136 1976 316 319
82. D.P. Thomas, V.J. Ream, and R.K. Stuart Platelet aggregation in patients with Laennec's cirrhosis of the liver N Engl J Med 276 1967 1344 1348
83. L. Albornoz, J.C. Bandi, and J.C. Otaso Prolonged bleeding time in experimental cirrhosis: role of nitric oxide J Hepatol 30 1999 456 460
84. B.S. Coller Platelets and thrombolytic therapy N Engl J Med 322 1990 33 42
85. P. Pantaleo, F. Marra, and F. Vizzutti Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis Clin Sci (Lond) 106 2004 27 34
86. M.J. Sanchez-Roig, J. Rivera, and J.M. Moraleda Quantitative defect of glycoprotein Ib in severe cirrhotic patients Am J Hematol 45 1994 10 15
87. G. Laffi, F. Marra, and P. Gresele Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation Gastroenterology 103 1992 641 646
88. T. Vukovich, H. Teufelsbauer, and M. Fritzer Hemostasis activation in patients with liver cirrhosis Thromb Res 77 1995 271 278
89. F. Violi, D. Ferro, and S. Basili Prognostic value of clotting and fibrinolytic systems in a follow-up of 165 liver cirrhotic patients Hepatology 22 1995 96 100
90. C.M. Bakker, E.A. Knot, and J. Stibbe Disseminated intravascular coagulation in liver cirrhosis J Hepatol 15 1992 330 335
91. S. Coccheri, P.M. Mannucci, and G. Palareti Significance of plasma fibrinopeptide A and high molecular weight fibrinogen in patients with liver cirrhosis Br J Haematol 52 1982 503 509
92. H. Takahashi, W. Tatewaki, and K. Wada Thrombin and plasmin generation in patients with liver disease Am J Hematol 32 1989 30 35
93. G. Mombelli, G. Fiori, and R. Monotti Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease J Lab Clin Med 121 1992 83 90
94. B. Kemkes-Matthes, H. Bleyl, and K.J. Matthes Coagulation activation in liver diseases Thromb Res 64 1991 253 261
95. Z. Ben-Ari, E. Osman, and R.A. Hutton Disseminated intravascular coagulation in liver cirrhosis: fact or fiction? Am J Gastroenterol 94 1999 2977 2982
96. L. vanDeWater, J.M. Carr, and D. Aronson Analysis of elevated fibrin(ogen) degradation product levels in patients with liver disease Blood 67 1986 1468 1473
97. H.G. Schipper, and J.W. ten Cate Antithrombin III transfusion in patients with hepatic cirrhosis Br J Haematol 52 1982 25 33
98. F. Tacke, P. Schoffski, and C. Trautwein Tissue factor and thrombomodulin levels are correlated with stage of cirrhosis in patients with liver disease Blood Coagul Fibrinolysis 12 2001 539 545
99. M. Romero Gomez, E. Suarez Garcia, and D. Lopez Lacomba Antiphospholipid antibodies are related to portal vein thrombosis in patients with liver cirrhosis J Clin Gastroenterol 31 2000 237 240
100. T. Koster, A.D. Blann, and E. Briet Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis Lancet 345 1995 152 155
101. L. Amitrano, M.A. Guardascione, and V. Brancaccio Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis J Hepatol 40 2004 736 741
102. E. Ejlersen, T. Melsen, and J. Ingerslev Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices Scand J Gastroenterol 36 2001 1081 1085
103. A. Zivelin, L.V. Rao, and S.I. Rapaport Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors J Clin Invest 92 1993 2131 2140
104. K. Oka, and K. Tanaka Intravascular coagulation in autopsy cases with liver diseases Thromb Haemost 42 1979 564 570
105. I.R. Wanless, F. Wong, and L.M. Blendis Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension Hepatology 21 1995 1238 1247
106. G.V. Papatheodoridis, E. Papakonstantinou, and E. Andrioti Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis Gut 52 2003 404 409
107. M.A. Yerdel, B. Gunson, and D. Mirza Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome Transplantation 69 2000 1873 1881
108. L. Belli, F. Romani, and C.V. Sansalone Portal thrombosis in cirrhotics. A retrospective analysis Ann Surg 203 1986 286 291
109. F. Violi, D. Ferro, and S. Basili Ongoing prothrombotic state in the portal circulation of cirrhotic patients Thromb Haemost 77 1997 44 47
110. S.I. Rapaport Coagulation problems in liver disease Blood Coagul Fibrinolysis 11 Suppl 1 2000 S69 S74
111. A. Robert, and O. Chazouilleres Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio? Hepatology 24 1996 1392 1394
112. B.G. Gazzard, J.M. Henderson, and R. Williams The use of fresh frozen plasma or a concentrate of factor IX as replacement therapy before liver biopsy Gut 16 1975 621 625
113. P.M. Mannucci, F. Franchi, and N. Dioguardi Correction of abnormal coagulation in chronic liver disease by combined use of fresh-frozen plasma and prothrombin complex concentrates Lancet 2 1976 542 545
114. W.I. Youssef, F. Salazar, and S. Dasarathy Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study Am J Gastroenterol 98 2003 1391 1394
115. I. Spector, M. Corn, and H.E. Ticktin Effect of plasma transfusions on the prothrombin time and clotting factors in liver disease N Engl J Med 275 1966 1032 1037
116. L.M. Williamson, C.A. Llewelyn, and N.C. Fisher A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation Transfusion 39 1999 1227 1234
117. D.J. Perry Factor VII deficiency Br J Haematol 118 2002 689 700
118. Y.J. Wang, N.H. He, and Z.W. Wang Assessment of the combined effect of plasma exchange and plasma perfusion on patients with severe hepatitis awaiting orthotopic liver transplantation Int J Artif Organs 27 2004 40 44
119. A.L. Singer, K.M. Olthoff, and H. Kim Role of plasmapheresis in the management of acute hepatic failure in children Ann Surg 234 2001 418 424
120. R. Lorenz, J. Kienast, and U. Otto Efficacy and safety of a prothrombin complex concentrate with two virus-inactivation steps in patients with severe liver damage Eur J Gastroenterol Hepatol 15 2003 15 20
121. M. Kohler Thrombogenicity of prothrombin complex concentrates Thromb Res 95 Suppl. 1 1999 S13 S17
122. D.M. Monroe, M. Hoffman, and J.A. Oliver Platelet activity of high-dose factor VIIa is independent of tissue factor Br J Haematol 99 1997 542 547
123. A. Anantharaju, K. Mehta, and A.L. Mindikoglu Use of activated recombinant human factor VII (rhFVIIa) for colonic polypectomies in patients with cirrhosis and coagulopathy Dig Dis Sci 48 2003 1414 1424
124. L. Jeffers, N. Chalasani, and L. Balart Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy Gastroenterology 123 2002 118 126
125. J.B. Brown, K.M. Emerick, and D.L. Brown Recombinant factor VIIa improves coagulopathy caused by liver failure J Pediatr Gastroenterol Nutr 37 2003 268 272
126. V.M. Shami, S.H. Caldwell, and E.E. Hespenheide Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy Liver Transpl 9 2003 138 143
127. T. Surudo, M. Wojcicki, and P. Milkiewicz Rapid correction of prothrombin time after low-dose recombinant factor VIIA in patients undergoing orthotopic liver transplantation Transplant Proc 35 2003 2323 2325
128. A. Chuansumrit, S. Treepongkaruna, and P. Phuapradit Combined fresh frozen plasma with recombinant factor VIIa in restoring hemostasis for invasive procedures in children with liver diseases Thromb Haemost 85 2001 748 749
129. G.V. Papatheodoridis, S. Chung, and S. Keshav Correction of both prothrombin time and primary haemostasis by recombinant factor VII during therapeutic alcohol injection of hepatocellular cancer in liver cirrhosis J Hepatol 31 1999 747 750
130. A.L. Mindikoglu, A. Anantharaju, and J. Villanueva Pericardiocentesis and pancreatic aspiration needle biopsy in coagulopathic and thrombocytopenic cirrhotic patient Chest 123 2003 956 958
131. H.G. Hendriks, K. Meijer, and J.T. de Wolf Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study Transplantation 71 2001 402 405
132. J.F. Lucia, C. Aguilar, and E. Orna Successful outcome of a cirrhotic patient with postoperative haematuria treated with a single high dose of recombinant factor VIIa Haemophilia 7 2001 600 602
133. A.M. Berthier, A. Guillygomarc'h, and M. Messner Use of recombinant factor VIIa to treat persistent bleeding following dental extractions in two cirrhotic patients Vox Sang 82 2002 119 121
134. R. Romero-Castro, M. Jimenez-Saenz, and F. Pellicer-Bautista Recombinant-activated factor VII as hemostatic therapy in eight cases of severe hemorrhage from esophageal varices Clin Gastroenterol Hepatol 2 2004 78 84
135. N.M. O'Connell, D.J. Perry, and A.J. Hodgson Recombinant FVIIa in the management of uncontrolled hemorrhage Transfusion 43 2003 1711 1716
136. S.H. Caldwell, C. Chang, and B.G. Macik Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: a break from convention in need of controlled trials Hepatology 39 2004 592 598
137. P.M. Mannucci, V. Vicente, and L. Vianello Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time Blood 67 1986 1148 1153
138. M. Cattaneo, P.M. Tenconi, and I. Alberca Subcutaneous desmopressin (DDAVP) shortens the prolonged bleeding time in patients with liver cirrhosis Thromb Haemost 64 1990 358 360
139. A.K. Burroughs, K. Matthews, and M. Qadiri Desmopressin and bleeding time in patients with cirrhosis Br Med J (Clin Res Ed) 291 1985 1377 1381
140. G. Agnelli, P. Parise, and M. Levi Effects of desmopressin on hemostasis in patients with liver cirrhosis Haemostasis 25 1995 241 247
141. R. de Franchis, P.G. Arcidiacono, and L. Carpinelli Randomized controlled trial of desmopressin plus terlipressin vs. terlipressin alone for the treatment of acute variceal hemorrhage in cirrhotic patients: a multicenter, double-blind study Hepatology 18 1993 1102 1107
142. A.Y. Wong, M.G. Irwin, and T.W. Hui Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy Can J Anaesth 50 2003 14 20
143. R. Scherer, M. Kabatnik, and J. Erhard The influence of antithrombin III (AT III) substitution to supranormal activities on systemic procoagulant turnover in patients with end-stage chronic liver disease Intensive Care Med 23 1997 1150 1158
144. T.G. DeLoughery, J.M. Liebler, and V. Simonds Invasive line placement in critically ill patients: do hemostatic defects matter? Transfusion 36 1996 827 831
145. P.A. McVay, and P.T. Toy Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities Transfusion 31 1991 164 171
146. D.B. McGill, J. Rakela, and A.R. Zinsmeister A 21-year experience with major hemorrhage after percutaneous liver biopsy Gastroenterology 99 1990 1396 1400
147. I.T. Gilmore, A. Burroughs, and I.M. Murray-Lyon Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London Gut 36 1995 437 441
148. F. Piccinino, E. Sagnelli, and G. Pasquale Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies J Hepatol 2 1986 165 173
149. A.S. Mahal, C.M. Knauer, and P.B. Gregory Bleeding after liver biopsy West J Med 134 1981 11 14
150. W.H. Jacobs, and S.B. Goldberg Statement on outpatient percutaneous liver biopsy Dig Dis Sci 34 1989 322 323
151. M. Sue, S.H. Caldwell, and R.C. Dickson Variation between centers in technique and guidelines for liver biopsy Liver 16 1996 267 270
152. W. Mayoral, and J.H. Lewis Percutaneous liver biopsy: what is the current approach? Results of a questionnaire survey Dig Dis Sci 46 2001 118 127
153. P.A. McVay, and P.T. Toy Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities Am J Clin Pathol 94 1990 747 753
154. K. Ewe Bleeding after liver biopsy does not correlate with indices of peripheral coagulation Dig Dis Sci 26 1981 388 393
155. J.F. Dillon, K.J. Simpson, and P.C. Hayes Liver biopsy bleeding time: an unpredictable event J Gastroenterol Hepatol 9 1994 269 271
156. W.B. Inabnet, and D.J. Deziel Laparoscopic liver biopsy in patients with coagulopathy, portal hypertension, and ascites Am Surg 61 1995 603 606
157. U. Denzer, I. Helmreich-Becker, and P.R. Galle Liver assessment and biopsy in patients with marked coagulopathy: value of mini-laparoscopy and control of bleeding Am J Gastroenterol 98 2003 893 900
158. P. Sharma, G.B. McDonald, and M. Banaji The risk of bleeding after percutaneous liver biopsy: relation to platelet count J Clin Gastroenterol 4 1982 451 453
159. E. Caturelli, M.M. Squillante, and A. Andriulli Fine-needle liver biopsy in patients with severely impaired coagulation Liver 13 1993 270 273
160. K.M. Boberg, F. Brosstad, and T. Egeland Is a prolonged bleeding time associated with an increased risk of hemorrhage after liver biopsy? Thromb Haemost 81 1999 378 381
161. A. Grant, and J. Neuberger Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology Gut 45 Suppl 4 1999 IV1 IV11
162. L. Amitrano, M.A. Guardascione, and V. Brancaccio Coagulation disorders in liver disease Semin Liver Dis 22 2002 83 96
163. A.A. Bravo, S.G. Sheth, and S. Chopra Liver biopsy N Engl J Med 344 2001 495 500
164. J. Martinez, and C. Barsigian Coagulopathy of liver failure and vitamin K deficiency J. Loscalzo A.I. Schafer Thrombosis and hemorrhage 2003 Lippincott Williams & Wilkins New York 803 815
165. P.W. Kamphuisen, T.G. Wiersma, and C.J. Mulder Plugged-percutaneous liver biopsy in patients with impaired coagulation and ascites Pathophysiol Haemost Thromb 32 2002 190 193
166. A.T. Blei, S. Olafsson, and S. Webster Complications of intracranial pressure monitoring in fulminant hepatic failure Lancet 341 1993 157 158
167. P.F. Foster, L.R. Moore, and H.N. Sankary Central venous catheterization in patients with coagulopathy Arch Surg 127 1992 273 275
168. G. Goldfarb, and D. Lebrec Percutaneous cannulation of the internal jugular vein in patients with coagulopathies: an experience based on 1,000 attempts Anesthesiology 56 1982 321 323
169. M.E. Doerfler, B. Kaufman, and A.S. Goldenberg Central venous catheter placement in patients with disorders of hemostasis Chest 110 1996 185 188
170. N.C. Fisher, and D.J. Mutimer Central venous cannulation in patients with liver disease and coagulopathy-a prospective audit Intensive Care Med 25 1999 481 485
171. B.A. Runyon Paracentesis of ascitic fluid. a safe procedure Arch Intern Med 146 1986 2259 2261
172. A. Mallory, and J.W. Schaefer Complications of diagnostic paracentesis in patients with liver disease JAMA 239 1978 628 630
173. B.A. Runyon Management of adult patients with ascites caused by cirrhosis Hepatology 27 1998 264 272
174. E.W. Friedman, and I.I. Sussman Safety of invasive procedures in patients with the coagulopathy of liver disease Clin Lab Haematol 11 1989 199 204
175. C.M. Grabau, S.F. Crago, and L.K. Hoff Performance standards for therapeutic abdominal paracentesis Hepatology 40 2004 484 488
176. B.A. Runyon Management of adult patients with ascites due to cirrhosis Hepatology 39 2004 841 856
177. K.P. Moore, F. Wong, and P. Gines The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club Hepatology 38 2003 258 266
178. J.W. Sokolowski Jr, L.W. Burgher, and F.L. Jones Jr Guidelines for thoracentesis and needle biopsy of the pleura Am Rev Respir Dis 140 1989 257 258
179. Health and Public Policy Committee, American College of Physicians Diagnostic thoracentesis and pleural biopsy in pleural effusions Ann Intern Med 103 1985 799 802